EIB to co-finance Brainlab research
The European Investment Bank (EIB), the long-term lending institution of the European Union owned by its Member States, has signed a €50 million loan to co-finance the R&D programme of Brainlab AG for two years. The loan comes with a guarantee from the European Fund for Strategic Investments (EFSI), also known as the Juncker Plan. The funding will support Brainlab’s R&D activities related to surgery, radiosurgery treatment and digital health.
EIB Vice-President responsible for financing in Germany Ambroise Fayolle said: “Brainlab is a highly innovative health tech company that develops effective solutions to accelerate surgery procedures in hospitals, using AI and big data. The technology has strategic importance for the digitalisation of healthcare and makes the data collected usable for future diagnostics and medical research. We are pleased to work with Brainlab to drive medical innovation.”
Founder and CEO of Brainlab Stefan Vilsmeier said: “As we look to the future, it’s important to understand and embrace digitalisation and the technology that will usher in a new era in the healthcare industry’s transformation. Innovation that delivers data-driven, patient-specific treatment is the future and we’re already working on the next breakthrough. This new capital, earmarked for strategic R&D fields will help us continue to make an impact on the lives of physicians and patients.”
Further Information: Germany: EIB to co-finance Brainlab Research & Development with €50 million loan